Nanobiotix S.A. (NBTX) Form 424B5 — May 22, 2026
Nanobiotix S.A. (NBTX) has priced a global offering of 2,184,662 ordinary shares and 345,099 pre-funded warrants, raising gross proceeds of approximately $98.6 million. The ADSs are being sold at $38.98 per share, which represents a discount to the last reported market price of $46.20 on May 19, 2026. The company intends to use the net proceeds of approximately $91.8 million to accelerate the development of its lead product candidate JNJ-1900 (NBTXR3) and advance its Curadigm Nanoprimer platform.
Key figures
- Cash Position
- 52800000
- Offering Price
- 38.98
- Shares Offered
- 2184662
- Net proceeds eur
- 79120000
- Net proceeds usd
- 91780000
- Dilution per share eur
- 33.71
- Last sale price ads usd
- 46.2
- Pre funded warrants offered
- 345099
- Shares outstanding dec 2025
- 48410068
- Last sale price ordinary eur
- 38.48
- Pre funded warrant price eur
- 33.57
- Jnj 1900 milestone payments usd
- 200000000
- Pre funded warrant exercise price eur
- 0.03
Price after filing
Close on the filing date to close N calendar days later (from $40.18). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.